| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Chairman | Director
5 companies
Marcus Joel S is a Director at Atara Biotherapeutics, Inc. with holdings across 5 companies. Recent SEC Form 4 filings include 2 buys and 10 sells.
Estimated insider holdings value: $43.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2020 | ARE Alexandria Real Estate Equities, Inc. | Executive Chairman | Sell | 10,000 | $156.82 | $1,568,200.00 | -2.3% | |
| Feb 12, 2020 | ARE Alexandria Real Estate Equities, Inc. | Executive Chairman | Sell | 35,000 | $173.00 | $6,055,000.00 | -7.6% | |
| Jan 28, 2020 | APLT Applied Therapeutics, Inc. | Director | Buy | 500 | $45.50 | $22,750.00 | +0.1% | |
| Sep 27, 2019 | ARE Alexandria Real Estate Equities, Inc. | Executive Chairman | Sell | 7,500 | $154.49 | $1,158,675.00 | -1.7% | |
| Sep 6, 2019 | ARE Alexandria Real Estate Equities, Inc. | Executive Chairman | Sell | 9,750 | $152.75 | $1,489,312.50 | -2.1% | |
| Aug 9, 2019 | ARE Alexandria Real Estate Equities, Inc. | Executive Chairman | Sell | 25,000 | $145.93 | $3,648,250.00 | -2.6% | |
| Aug 2, 2019 | ARE Alexandria Real Estate Equities, Inc. | Executive Chairman | Sell | 20,000 | $145.10 | $2,902,000.00 | -2.0% | |
| May 16, 2019 | APLT Applied Therapeutics, Inc. | Director | Buy | 150,000 | $10.00 | $1,500,000.00 | +58.9% | |
| Mar 15, 2019 | ATRA Atara Biotherapeutics, Inc. | Director | Sell | 20,000 | $38.25 | $765,000.00 | -2.2% | |
| Feb 28, 2019 | ATRA Atara Biotherapeutics, Inc. | Director | Sale+OE | 62,590 | $36.07 | $2,257,621.30 | -89.3% |